Cardiology, Diabetes & Nephrology at the Limits 2019: Multimedia

Monday 8th - Wednesday 10th April 2019

How the gut talks to the brain and protects the heart and kidneys
Professor Carel le Roux
Director of Metabolic Medicine Group, University College Dublin, Ireland

---

Are pleiotropic effects of GLP-1 agonists clinically important?
Professor Lars Ryden
The Karolinska Institute, Sweden

---

At the limits of lipid management – statins to PCSK9 inhibitors
Dr Erin Bohula May
Brigham & Women’s Hospital, Harvard Medical School, Boston, USA

---

Heart failure – are there limits to anti-diabetic therapy with SGLT2 inhibitors?
Professor Milton Packer
Baylor University Medical Center, Dallas, Texas, USA

---

Cross talk between kidney and circulation in diabetes
Professor Katherine Tuttle
University of Washington, Washington State, USA

---

Cardiovascular & renal complications in pregnancy: cardiovascular
Professor Karen Sliwa
University of Cape Town, SA

---

Cardiovascular & renal complications in pregnancy: renal
Professor Nigel Brunskill
University of Leicester, UK

---

Drugs & devices: what are the limits to cardiac dysrhythmias?
Professor John Camm
St Georges Hospital, University of London, UK

---

Smoke & mirrors in the world of nutrition
Professor Mike Lean
University of Glasgow, UK

---

Thrombolysis and device therapy for acute stroke – pushing the limits!
Professor Alan Bryer
University of Cape Town, South Africa

---

Vitamin D - panacea or much ado about nothing?
Professor Ravi Thadhani
Cedar-Sinai, Los Angeles, USA

---

Ageing, cancer & CV disease – do they have a common root?
Professor Peter Libby
Brigham & Women’s Hospital, Harvard Medical School, Boston, USA

---